Biggest News Aggregation in the World
๐Ÿ“ฐ Sci Communications News

Page 4 - Sci Communications News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Sci Communications. Real-time updates on events, politics, business and more.

9 Meters Biopharma to Present at the H.C. Wainwright Global Investment Conference and the LifeSci Partners Immunology & Inflammation Symposium

RALEIGH, NC / ACCESSWIRE / May 5, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, announced
John Temperato Al Medwar Veronica Eames Lifesci Communications Meters Biopharma Inc Investor Relations Corporate Communications

9 Meters Biopharma and Celiac.com Announce Collaboration to Support Clinical Trial Enrollment in 9 Meter's Phase 3 Study for Celiac Disease

RALEIGH, NC and SANTA ROSA, CA / ACCESSWIRE / April 20, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive
Al Medwar Veronica Eames Scott Adams Patrick Griffin Lifesci Communications Meters Biopharma Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

9 Meters Biopharma to Present at the Oppenheimer 32nd Annual Healthcare Conference

09.03.2022 - RALEIGH, NC / ACCESSWIRE / March 9, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, announced today that John Temperato, President & Chief ...
Al Medwar Veronica Eames Company Annual Report On Form Lifesci Communications Meters Biopharma Inc Investor Relations Corporate Communications

Mundipharma and Cidara Therapeutics, Inc.: Rezafungin Awarded Promising Innovation Medicine (PIM) Designation by the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) for the Treatment of Invasive Candidiasis

For Trade and Medical Media Only Rezafungin is a next-generation once-weekly echinocandin being developed for both the treatment and prevention of serious fungal infections, such as invasive candidiasis
United States San Diego United Kingdom Taylor Sandison Patrick Bursey Brian Sheehan

9 Meters Biopharma Announces a Collaboration with NYU Langone Health Investigating NM-102 as a Potential Treatment for an Autoimmune Disorder

RALEIGH, NC / ACCESSWIRE / March 2, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, announced
Al Medwar Patrickh Griffin Gregg Silverman Veronica Eames Langone Health Langone Judith Stewart Colton Center

9 Meters Biopharma : Provides Clinical Update on Late-Stage Pipeline Products Vurolenatide for Short Bowel Syndrome and Larazotide for Celiac Disease - Form 8-K

9 Meters Biopharma Provides Clinical Update on Late-Stage Pipeline Products Vurolenatide for Short Bowel Syndrome and Larazotide for Celiac Disease RALEIGH, NC... | February 28, 2022
Al Medwar John Temperato Patrickh Griffin Veronica Eames Company Annual Report On Form Company Phase

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science